Related Experiment Video
Updated: Jul 15, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Limiting access to letrozole--is it justified?
Togas Tulandi1, Alan H DeCherney
1Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada. togas.tulandi@mcgill.ca
Fertility and Sterility
|April 28, 2007
Summary
Letrozole effectively induces ovulation and superovulation. Restricting access to this drug hinders treatment for infertility and limits crucial research in reproductive science.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Background:
- Letrozole is a well-established medication for inducing ovulation.
- Ovulation induction is a critical component of infertility treatment.
Discussion:
- Current limitations on letrozole access negatively impact infertile patients.
- Restricted availability impedes progress in ovulation-related scientific research.
Key Insights:
- Letrozole demonstrates significant efficacy in ovulation and superovulation.
- Access restrictions pose a dual problem for patient care and research advancement.
Outlook:
- Future research should focus on optimizing letrozole accessibility.
- Expanding access may accelerate discoveries in reproductive medicine and endocrinology.
